Article Text

Download PDFPDF
Making cardiac rehabilitation more available and affordable
  1. Carl J Lavie,
  2. Sergey Kachur,
  3. Richard V Milani
  1. John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana, USA
  1. Correspondence to Dr Carl J Lavie, John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA 70121, USA; clavie{at}ochsner.org

Statistics from Altmetric.com

Substantial evidence demonstrates the critical role of cardiac rehabilitation and exercise training (CRET) programmes following major coronary heart disease (CHD) events.1 Although a recent meta-analysis has questioned the impact of CRET on total mortality,2 there is still substantial evidence that this therapy reduces cardiovascular disease (CVD) mortality and improves overall prognosis following major CHD events.1–3 Additionally, this therapy has dramatic effects to improve CHD risk factors, exercise capacity, psychological risk factors associated with higher mortality and overall health-related quality of life (HRQoL).1 3 4

However, as we recently reviewed, the majority of candidates for CRET do not actually attend these programmes,1 4 and greater efforts are needed to make these programmes more available to patients in rural areas, those which transportation or employment issues, as well as efforts to make this therapy even more ‘cost effective’ for our patients.

In their Heart paper, Maddison and colleagues5 from Australia and New Zealand report on a randomised controlled trial of CRET, with …

View Full Text

Footnotes

  • Contributors All authors contributed to the review of the primary paper and literature review and were part of the Original Ochsner studies discussed; this is a Review/Editorial, but all authors reviewed and edited the manuscript and approved the final paper.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles